TRUL.CN - Trulieve Cannabis Corp.
| Previous Close | 13.93 |
| Open | 14.09 |
| Bid | 13.49 x 0 |
| Ask | 13.81 x 0 |
| Day's Range | 13.57 - 14.20 |
| 52 Week Range | 9.10 - 23.85 |
| Volume | 60,738 |
| Avg. Volume | 249,005 |
| Market Cap | 1.498B |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | 28.39 |
| EPS (TTM) | 0.48 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CNW Group•4 days agoTrulieve Opens 29th Florida Dispensary, Bringing Natural Relief to Patients in Central Florida
ORLANDO, FL, June 21, 2019 /CNW/ - Trulieve Cannabis Corp. (CSE: TRUL & OTC: TCNNF) ("Trulieve" or "the company"), a leading and top-performing cannabis company in the United States, announced it is opening the doors of its 29th storefront in Florida with a new dispensary in Orlando. The store, which is their second in the area, will offer natural relief to patients throughout the Central Florida area. "We're excited to expand our reach in the Central Florida area and further ensure consistent, safe, and reliable patient access.
- CNW Group•7 days ago
IIROC Trade Resumption - TRUL.WT
VANCOUVER , June 18, 2019 /CNW/ - Trading resumes in: Company: Trulieve Cannabis Corp. CSE Symbol: TRUL.WT Resumption (ET): 12:15 IIROC can make a decision to impose a temporary suspension (halt) of trading ...
CNW Group•7 days agoTrulieve Announces Closing of Public Offering of Units
TORONTO, June 18, 2019 /CNW/ - Trulieve Cannabis Corp. ("Trulieve" or the "Company") (CSE:TRUL.CN - News) is pleased to announce it has closed its previously announced public offering (the "Offering") of units of the Company ("Units") comprised of an aggregate principal amount of US$70,000,000 of 9.75% senior secured notes maturing in 2024 (the "Notes") and an aggregate amount of 1,470,000 subordinate voting share warrants (the "Warrants"). Pursuant to the Offering the Company issued an aggregate of 70,000 Units at a price of US$980 per Unit for gross proceeds of US$68,600,000. Each Unit is comprised of one Note and 21 Warrants. Each Warrant is exercisable for three years to purchase one subordinate voting share of the Company ("Subordinate Voting Share") at an exercise price of C$17.25 per share, subject to adjustment in certain events.
CNW Group•11 days agoTrulieve CEO Kim Rivers Named to Florida Medical Marijuana Advisory Committee
TORONTO, June 14, 2019 /CNW/ - Trulieve Cannabis Corp. ("Trulieve" or the "Company") (CSE:TRUL.CN - News) CEO Kim Rivers has been appointed to the newly-established Medical Marijuana Advisory Committee for the State of Florida. This committee will collaborate with the Florida Department of Agriculture and Consumer Services to help enhance the medical marijuana policies of the state. "Every day, our Trulieve team helps to bring relief to thousands of people suffering from a range of debilitating ailments and improve their quality of life," said Kim Rivers, CEO of Trulieve.
- CNW Group•14 days ago
Trulieve Announces Pricing of Public Offering of Units
TORONTO, June 11, 2019 /CNW/ - Trulieve Cannabis Corp. ("Trulieve" or the "Company") (CSE:TRUL.CN - News) today announced that it has priced its previously announced public offering (the "Offering") of units of the Company ("Units") comprised of an aggregate principal amount of US$70,000,000 of 9.75% senior secured notes maturing in 2024 (the "Notes") and an aggregate amount of 1,470,000 subordinate voting share warrants (the "Warrants"). Pursuant to the Offering the Company will issue an aggregate of 70,000 Units at a price of US$980 per Unit for gross proceeds of US$68,600,000. Each Unit will consist of one Note and 21 Warrants. Each Warrant will be exercisable for three years to purchase one subordinate voting share of the Company ("Subordinate Voting Share") at an exercise price of C$17.25 per share, subject to adjustment in certain events.
- CNW Group•15 days ago
Trulieve Announces Proposed Public Offering Of Units
TORONTO, June 10, 2019 /CNW/ - Trulieve Cannabis Corp. ("Trulieve" or the "Company") (CSE:TRUL.CN - News) today announced that it has filed a preliminary prospectus supplement (the "Preliminary Supplement") to its short form base shelf prospectus dated May 14, 2019 (the "Base Shelf Prospectus") relating to a proposed public offering (the "Offering") of units of the Company ("Units"). Pursuant to the Offering, Canaccord Genuity Corp. (the "Agent") will act as the exclusive agent, on a "best-efforts" basis. The Offering will be priced in the context of the market with the number of Units, issue price of the Units, number of Warrants and exercise price thereof, and total size of the Offering to be determined at the time of entering into an agency agreement for the Offering.
- Baystreet•19 days ago
Extracts Supply Demand Heightens with Surging Alternative Cannabis Markets
Later this year another large legal cannabis market will open up, with the lifting of prohibition ...